Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Us Nuclear (UCLE) Cash & Equivalents (2017 - 2025)

Us Nuclear (UCLE) has disclosed Cash & Equivalents for 9 consecutive years, with $75907.0 as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents rose 138.87% to $75907.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $75907.0 through Sep 2025, up 138.87% year-over-year, with the annual reading at $130840.0 for FY2024, 14.39% down from the prior year.
  • Cash & Equivalents hit $75907.0 in Q3 2025 for Us Nuclear, up from $46285.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $420907.0 in Q2 2022 to a low of $31778.0 in Q3 2024.
  • Historically, Cash & Equivalents has averaged $160789.9 across 5 years, with a median of $132191.0 in 2024.
  • Biggest five-year swings in Cash & Equivalents: soared 225.31% in 2023 and later crashed 82.8% in 2024.
  • Year by year, Cash & Equivalents stood at $246317.0 in 2021, then tumbled by 48.8% to $126109.0 in 2022, then rose by 21.2% to $152840.0 in 2023, then dropped by 14.39% to $130840.0 in 2024, then tumbled by 41.98% to $75907.0 in 2025.
  • Business Quant data shows Cash & Equivalents for UCLE at $75907.0 in Q3 2025, $46285.0 in Q2 2025, and $68489.0 in Q1 2025.